window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 28, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Featured

  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Tezspire meets Phase 3 endpoints in eosinophilic esophagitis

    AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

    August 28, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Agenus reports deep responses with immunotherapy in Phase 2 colon cancer study

    Agenus has reported deep tumour responses and no observed colorectal [...]

    August 27, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development

    CEPI funds Minapharm’s Phase 1 Bundibugyo Ebola vaccine programme

    CEPI will provide up to $16.5 million to Minapharm to [...]

    August 27, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Sagimet prepares Phase 3 acne trial for first US patients

    Sagimet Biosciences is preparing to begin screening patients for its [...]

    August 27, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    FDA approves ViiV’s Tivicay PD for young children with HIV

    The FDA has approved ViiV Healthcare’s Tivicay PD for children [...]

    August 26, 2026
  • Clinical & Regulatory,Medical devices,Research & Development,Therapeutic Areas

    MRI study suggests some prostate cancer biopsies could eventually be avoided

    A study of 880 men found clinically significant prostate cancer [...]

    August 26, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Leicester clinic offers Galleri blood test following NHS cancer trial

    A Leicester private GP clinic has begun offering Galleri, a [...]

    August 24, 2026
  • Manufacturing & Supply Chain

    TraceLink MINT transaction volume surges 183% in 2026

    TraceLink’s MINT platform has recorded more supply chain transaction activity [...]

    August 24, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Wiley launches spectral analysis APIs for faster compound identification

    Wiley has launched a portfolio of spectral analysis APIs designed [...]

    August 19, 2026
  • Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Pusan National University study links stress signalling to immune escape in cold tumours

    A Pusan National University study has identified a signalling pathway [...]

    August 19, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • NIH funds expanded access programme for Neurizon’s ALS therapy
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Sapience Therapeutics gets FDA clearance for ST316 FAP study
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • EURneffy recommended for emergency anaphylaxis treatment in NHS Wales
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top